Anthony H. Cincotta, PHD

Co-Chair, Chief Science Officer & Founder

Dr. Cincotta is the co-chair of the company and is responsible for overseeing all research and development. He earned his PhD from Louisiana State University in biochemical physiology. He has over 27 years experience in clinical research and development and is recognized as one of the world’s leading authorities on biological clock regulation of metabolism, metabolic syndrome and Circadian Neuroendrocrine Resetting Therapy.

Brian Shrader

Co-Chair, Chief Financial Officer & Founder

Brian Shrader has been in the financial industry over 25 years, acting as Chief Financial Officer for major pharmaceutical companies such as King Pharmaceuticals Inc.